PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Levonorgestrel intrauterine system - Menopausal disorders

PAD Profile : Levonorgestrel intrauterine system - Menopausal disorders

Keywords :
Menopause, hot sweats, mood swings, anxiety, weight gain, iUS, menopausal symptoms, HRT hormone replacement therapy, levonorgestrel releasing
Brand Names Include :
Mirena, Benilexa

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Important
Formulations :
  • Intrauterine device (progestogen only)
Important Information :
Benilexa (approved at DTC Oct23)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date
Webpage
NICE NG23 menopause-diagnosis-and-management

Committee Recommendations

Date
Committee Name
Narrative
06 May 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Surrey & North West Sussex Area Prescribing Committee updated their recommendations in line with NICE guidance NG23 Menopause diagnosis and management in May 2020.

Mirena is recommended for menopausal symptoms and a GREEN traffic light status has been agreed. Please refer to the Menopause -NG23 briefing paper attached below for further information (Page 11/12).  The Mirena® IUS (52 mg LNG) is the only intrauterine system licensed as part of HRT and needs to be
changed every 5 years (licensed for 4 years; recommended by the Faculty of Sexual and Reproductive Healthcare (FRSH) and licensed in other EU countries for 5 years)

Associated BNF Codes

06. Endocrine System
06.04.01. Female sex hormones and their modulators
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More